Article Information
History
- February 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Susan E Manzoor1,
- Shafquat Zaman2,
- Celina Whalley2,
- David Inglis4,
- Andrew Bosworth2,
- Michael Kidd2,
- Sahida Shabir1,
- Nabil Quraishi2,
- Christopher A Green3,
- Tariq Iqbal4,* and
- Andrew D Beggs2,*,†
- 1Microbiome Treatment Centre, University of Birmingham
- 2Institute of Cancer & Genomic Science, University of Birmingham
- 3Institute of Microbiology & Infection, University of Birmingham
- 4Institute of Immunology & Immunotherapy, University of Birmingham
- ↵†Correspondence to: Professor Andrew Beggs, Institute of Cancer & Genomic Sciences, University of Birmingham, Vincent Drive, Birmingham, B15 2TT, United Kingdom, Email: a.beggs{at}bham.ac.uk
↵* Authors contributed equally to the manuscript
Competing interests: ADB – has received travel funding to the Oxford Nanopore Community Meeting 2019 from Oxford Nanopore. The rest of the authors declare no competing interests.